DE60209248D1 - Verwendung von (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propinyl)-estra-4,9-dien-3-on zur behandlung von schweren depressionen - Google Patents

Verwendung von (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propinyl)-estra-4,9-dien-3-on zur behandlung von schweren depressionen

Info

Publication number
DE60209248D1
DE60209248D1 DE60209248T DE60209248T DE60209248D1 DE 60209248 D1 DE60209248 D1 DE 60209248D1 DE 60209248 T DE60209248 T DE 60209248T DE 60209248 T DE60209248 T DE 60209248T DE 60209248 D1 DE60209248 D1 DE 60209248D1
Authority
DE
Germany
Prior art keywords
estra
benzodioxol
dien
hydroxy
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60209248T
Other languages
German (de)
English (en)
Inventor
Cornelis Sennef
Bernardus Wijnand M Peeters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE60209248D1 publication Critical patent/DE60209248D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60209248T 2001-10-26 2002-10-21 Verwendung von (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propinyl)-estra-4,9-dien-3-on zur behandlung von schweren depressionen Expired - Lifetime DE60209248D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204072 2001-10-26
PCT/EP2002/011732 WO2003037354A1 (en) 2001-10-26 2002-10-21 USE OF (11β, 17β)-11-(1,3-BENZODIOXOL-5-YL)-17-HYDROXY-17-(1-PROPYNYL)-ESTRA-4,9-DIEN-3-ONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER

Publications (1)

Publication Number Publication Date
DE60209248D1 true DE60209248D1 (de) 2006-04-20

Family

ID=8181136

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60209248T Expired - Lifetime DE60209248D1 (de) 2001-10-26 2002-10-21 Verwendung von (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propinyl)-estra-4,9-dien-3-on zur behandlung von schweren depressionen
DE60230936T Expired - Lifetime DE60230936D1 (de) 2001-10-26 2002-10-21 Verwendung von (11beta, 17beta)-11-(1,3-Benzodioxol-5-yl)-17-Hydroxy-17-(1-Propinyl)-estra-4,9-dien-3-on zur Behandlung von schweren Depressionen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60230936T Expired - Lifetime DE60230936D1 (de) 2001-10-26 2002-10-21 Verwendung von (11beta, 17beta)-11-(1,3-Benzodioxol-5-yl)-17-Hydroxy-17-(1-Propinyl)-estra-4,9-dien-3-on zur Behandlung von schweren Depressionen

Country Status (26)

Country Link
US (1) US20040266863A1 (enExample)
EP (2) EP1441739B1 (enExample)
JP (1) JP4647909B2 (enExample)
KR (1) KR20050038580A (enExample)
CN (1) CN100531738C (enExample)
AT (2) ATE317700T1 (enExample)
AU (1) AU2002348996B2 (enExample)
BR (1) BR0213466A (enExample)
CA (1) CA2463446C (enExample)
CY (1) CY1110173T1 (enExample)
DE (2) DE60209248D1 (enExample)
DK (1) DK1652526T3 (enExample)
EC (1) ECSP045080A (enExample)
ES (1) ES2319563T3 (enExample)
HR (1) HRP20040370B1 (enExample)
HU (1) HUP0500070A3 (enExample)
IL (2) IL161248A0 (enExample)
IS (1) IS2702B (enExample)
MX (1) MXPA04003781A (enExample)
NO (1) NO332978B1 (enExample)
NZ (1) NZ532429A (enExample)
PL (1) PL206687B1 (enExample)
PT (1) PT1652526E (enExample)
RU (1) RU2302245C2 (enExample)
WO (1) WO2003037354A1 (enExample)
ZA (1) ZA200403088B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050080061A1 (en) * 2003-07-23 2005-04-14 Corcept Therapeutics, Inc. Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
AU2011236053B2 (en) * 2004-11-19 2014-06-26 Merck Sharpe & Dohme B.V. Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
EP2292269A3 (en) * 2004-11-19 2011-08-10 N.V. Organon Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
CA2649894A1 (en) * 2006-05-02 2007-11-15 Corcept Therapeutics, Inc. The use of a glucocorticoid receptor ii antagonist to treat depression in patients taking il-2
WO2012106514A2 (en) * 2011-02-03 2012-08-09 Pop Test Cortisol Llc System and method for diagnosis and treatment
EP2699245A4 (en) * 2011-04-18 2014-12-10 Pop Test Cortisol Llc TREATMENT AGAINST HAIR LOSS
US8986677B2 (en) * 2012-07-30 2015-03-24 Pop Test Cortisol Llc Therapeutic compositions and methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814333A (en) * 1987-07-28 1989-03-21 The Trustees Of Dartmouth College Method for treatment of hypercortisolemic, depressed patients
DE4447401A1 (de) * 1994-12-23 1996-07-04 Schering Ag 14,17-C¶2¶-überbrückte Steroide
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
DE19727772A1 (de) * 1997-06-30 1999-01-28 Forschungszentrum Juelich Gmbh Magnetflußsensor mit ringförmiger Sonde
CN1528315A (zh) * 1997-10-06 2004-09-15 ������˹̹�������ѧ�й�ίԱ�� 治疗糖皮质素功能失调相关性精神病的方法
CN1556709A (zh) * 2001-03-23 2004-12-22 �Ƹ��� 使用糖皮质激素受体特效拮抗剂治疗压力症的方法
IL158744A0 (en) * 2001-05-04 2004-05-12 Corcept Therapeutics Inc Methods for treating delirium using glucocorticoid receptor-specific antagonists
MXPA04001893A (es) * 2001-08-31 2005-03-07 Corcept Therapeutics Inc Metodos para inhibir deterioro cognoscitivo en adultos con sindrome de down.

Also Published As

Publication number Publication date
IL161248A0 (en) 2004-09-27
PL206687B1 (pl) 2010-09-30
PL369261A1 (en) 2005-04-18
HUP0500070A3 (en) 2012-09-28
IL161248A (en) 2010-12-30
WO2003037354A1 (en) 2003-05-08
RU2004116082A (ru) 2005-05-10
CA2463446A1 (en) 2003-05-08
EP1441739A1 (en) 2004-08-04
JP2005521637A (ja) 2005-07-21
EP1652526B1 (en) 2009-01-14
EP1652526A3 (en) 2006-08-02
HRP20040370B1 (hr) 2012-09-30
ATE317700T1 (de) 2006-03-15
PT1652526E (pt) 2009-02-06
EP1652526A2 (en) 2006-05-03
CA2463446C (en) 2010-02-23
IS7204A (is) 2004-03-31
NZ532429A (en) 2004-10-29
HRP20040370A2 (en) 2004-08-31
ZA200403088B (en) 2005-01-24
HUP0500070A2 (hu) 2005-04-28
CN100531738C (zh) 2009-08-26
NO20041651L (no) 2004-04-23
RU2302245C2 (ru) 2007-07-10
ECSP045080A (es) 2004-06-28
ES2319563T3 (es) 2009-05-08
MXPA04003781A (es) 2004-07-30
JP4647909B2 (ja) 2011-03-09
DK1652526T3 (da) 2009-05-18
US20040266863A1 (en) 2004-12-30
NO332978B1 (no) 2013-02-11
KR20050038580A (ko) 2005-04-27
IS2702B (is) 2010-11-15
BR0213466A (pt) 2004-11-09
CY1110173T1 (el) 2015-01-14
DE60230936D1 (de) 2009-03-05
AU2002348996B2 (en) 2008-06-05
CN1582153A (zh) 2005-02-16
HK1087357A1 (en) 2006-10-13
EP1441739B1 (en) 2006-02-15
ATE420649T1 (de) 2009-01-15

Similar Documents

Publication Publication Date Title
NO20042811L (no) Substituerte henzoksazoler og analoger som estrogene midler
ES2196063T3 (es) Utilizacion de agentes antagonistas competitivos de progesterona para la preparacion de medicamentos destinados al tratamiento de hemorragias uterinas disfuncionales.
ES2124905T3 (es) Esteroides antiglucocorticoides destinados al tratamiento de trastornos de ansiedad.
MXPA04005784A (es) 2-fenilbenzofuranos sustituidos como agentes estrogenitos.
NO20020282D0 (no) Nytt difenylpiperidinderivat
DE60115274D1 (de) Verwendung von antiprogestinen zur prophylaxe und behandlung von hormonabhängigen erkrankungen
CY1110173T1 (el) Χρηση της (11 beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one στη θεραπεια μειζωνος καταθλιπτικης διαταραχης
BR0213684A (pt) Uso de antagonistas do receptor de endotelina para o tratamento de doenças tumorìgenas
BR0208336A (pt) Novas amidas, preparação e uso terapêutico como moduladores de atividade de receptor-ccr
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
NO20014855D0 (no) N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister
DK1487859T3 (da) Fremstillingsmetoder til at fremstille Eplerenon
NO20014961L (no) Integrin-reseptor-ligander
ATE419855T1 (de) Therapie für hormonersatz und depression enthaltend dienogest
MX2007004461A (es) Composiciones farmaceuticas a base de antagonistas de nk2 para uso pediatrico.
NO20022712D0 (no) Umettede 14,15-syklopropanandrostaner, fremgangsmåte for deres fremstilling, og farmasöytiske preparater som inneholderdisse forbindelsene
DK1090028T3 (da) Umættede 14,15-cyclopropano-androstaner, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende disse forbindelser
NO974256L (no) Anvendelse av anti-östrogener som befruktningshindrende midler for menn
ATE218366T1 (de) Pharmazeutische zusammensetzung enthaltend factor xiiia für nervenheilung

Legal Events

Date Code Title Description
8372 Publication of ep patent withdrawn